2018 was a incredible boom year in the number of new biotech offerings. Author explores the data around post-IPO market performance and the challenging end of year in the stock market.
Biotech IPO Markets: Closing The Books On 2018’s Crazy Year
2018 was a incredible boom year in the number of new biotech offerings. Author explores the data around post-IPO market performance and the challenging end of year in the stock market.